[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK0781547T3 - Ophthalmisk formulering baseret på natriumhyaluronat til anvendelse i øjen-kirugi - Google Patents

Ophthalmisk formulering baseret på natriumhyaluronat til anvendelse i øjen-kirugi

Info

Publication number
DK0781547T3
DK0781547T3 DK96120457T DK96120457T DK0781547T3 DK 0781547 T3 DK0781547 T3 DK 0781547T3 DK 96120457 T DK96120457 T DK 96120457T DK 96120457 T DK96120457 T DK 96120457T DK 0781547 T3 DK0781547 T3 DK 0781547T3
Authority
DK
Denmark
Prior art keywords
sodium hyaluronate
eye surgery
ophthalmic formulation
formulation based
ophthalmic
Prior art date
Application number
DK96120457T
Other languages
English (en)
Inventor
Rene-Pierre Buenter
Original Assignee
Trb Chemedica S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Trb Chemedica S A filed Critical Trb Chemedica S A
Application granted granted Critical
Publication of DK0781547T3 publication Critical patent/DK0781547T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK96120457T 1995-12-22 1996-12-19 Ophthalmisk formulering baseret på natriumhyaluronat til anvendelse i øjen-kirugi DK0781547T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT95MI002744A IT1277707B1 (it) 1995-12-22 1995-12-22 Formulazione oftalmica a base di ialuronato di sodio per uso nella chirurgia oculare

Publications (1)

Publication Number Publication Date
DK0781547T3 true DK0781547T3 (da) 2002-08-12

Family

ID=11372809

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96120457T DK0781547T3 (da) 1995-12-22 1996-12-19 Ophthalmisk formulering baseret på natriumhyaluronat til anvendelse i øjen-kirugi

Country Status (10)

Country Link
US (1) US5880107A (da)
EP (1) EP0781547B1 (da)
JP (1) JP4146910B2 (da)
AT (1) ATE216221T1 (da)
CA (1) CA2193543C (da)
DE (1) DE69620724T2 (da)
DK (1) DK0781547T3 (da)
ES (1) ES2175020T3 (da)
IT (1) IT1277707B1 (da)
PT (1) PT781547E (da)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6541460B2 (en) 1996-08-07 2003-04-01 George D. Petito Method for use of hyaluronic acid in wound management
US6368585B1 (en) * 1997-03-25 2002-04-09 Pharmacia Ab Opthalmic compositions and methods
US20030138499A1 (en) * 1998-12-17 2003-07-24 Shah Mandar V. Stable surgical irrigating solutions
US6533769B2 (en) * 2001-05-03 2003-03-18 Holmen Joergen Method for use in cataract surgery
US7820194B2 (en) 2001-12-21 2010-10-26 Alcon, Inc. Combinations of viscoelastics for use during surgery
ITMI20020557A1 (it) * 2002-03-15 2003-09-15 Acraf Uso di un sale dell'acido l-ascorbico per preparare una composizione farmaceutica per uso topico oftalmico capace di migliorare il livello d
US20040167480A1 (en) * 2003-02-21 2004-08-26 Advanced Medical Optics, Inc. Administration of multiple viscoelastic solutions with a multi-compartment syringe
FR2861734B1 (fr) 2003-04-10 2006-04-14 Corneal Ind Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus
US20050215516A1 (en) * 2004-03-29 2005-09-29 Claudio Bucolo New free-radical scavenger containing viscoelastic composition, methods of use and package
US20060073184A1 (en) * 2004-09-29 2006-04-06 Bausch & Lomb Inc. Viscoelastic composition, methods of use and packaging device with anti-oxidant
US20080131522A1 (en) * 2006-10-03 2008-06-05 Qing Liu Use of placental biomaterial for ocular surgery
CA2687990A1 (en) * 2007-05-23 2008-12-04 Allergan, Inc. Cross-linked collagen and uses thereof
US8318695B2 (en) * 2007-07-30 2012-11-27 Allergan, Inc. Tunably crosslinked polysaccharide compositions
US8697044B2 (en) * 2007-10-09 2014-04-15 Allergan, Inc. Crossed-linked hyaluronic acid and collagen and uses thereof
US8114898B2 (en) 2007-11-16 2012-02-14 Allergan, Inc. Compositions and methods for treating purpura
US8394784B2 (en) 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having multi-stage bioactive agent delivery
US20090143348A1 (en) * 2007-11-30 2009-06-04 Ahmet Tezel Polysaccharide gel compositions and methods for sustained delivery of drugs
US8394782B2 (en) * 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having increased longevity
EP2229180A1 (en) * 2007-12-27 2010-09-22 D.M.G. Italia Srl Composition comprising superoxide dismutase and carboxv methyl beta-1,3 glucan
US8357795B2 (en) 2008-08-04 2013-01-22 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
US9228027B2 (en) 2008-09-02 2016-01-05 Allergan Holdings France S.A.S. Threads of Hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof
US20100104654A1 (en) * 2008-10-27 2010-04-29 Allergan, Inc. Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof
JP4885245B2 (ja) * 2009-01-15 2012-02-29 日本航空電子工業株式会社 Ｒｄコンバータ及び角度検出装置
WO2011075430A1 (en) * 2009-12-14 2011-06-23 University Of Massachusetts Methods of inhibiting cataracts and presbyopia
US9114188B2 (en) 2010-01-13 2015-08-25 Allergan, Industrie, S.A.S. Stable hydrogel compositions including additives
US20110171310A1 (en) * 2010-01-13 2011-07-14 Allergan Industrie, Sas Hydrogel compositions comprising vasoconstricting and anti-hemorrhagic agents for dermatological use
US20110171311A1 (en) * 2010-01-13 2011-07-14 Allergan Industrie, Sas Stable hydrogel compositions including additives
US20110172180A1 (en) 2010-01-13 2011-07-14 Allergan Industrie. Sas Heat stable hyaluronic acid compositions for dermatological use
KR101764451B1 (ko) 2010-03-12 2017-08-02 알러간 인더스트리 에스에이에스 피부 상태 개선을 위한 히알루론안 폴리머 및 만니톨을 포함하는 유체 조성물
US8691279B2 (en) 2010-03-22 2014-04-08 Allergan, Inc. Polysaccharide and protein-polysaccharide cross-linked hydrogels for soft tissue augmentation
US8889123B2 (en) 2010-08-19 2014-11-18 Allergan, Inc. Compositions and soft tissue replacement methods
US8883139B2 (en) 2010-08-19 2014-11-11 Allergan Inc. Compositions and soft tissue replacement methods
US9005605B2 (en) 2010-08-19 2015-04-14 Allergan, Inc. Compositions and soft tissue replacement methods
US8697057B2 (en) 2010-08-19 2014-04-15 Allergan, Inc. Compositions and soft tissue replacement methods
US9408797B2 (en) 2011-06-03 2016-08-09 Allergan, Inc. Dermal filler compositions for fine line treatment
US9393263B2 (en) 2011-06-03 2016-07-19 Allergan, Inc. Dermal filler compositions including antioxidants
US20130096081A1 (en) 2011-06-03 2013-04-18 Allergan, Inc. Dermal filler compositions
CA3038735C (en) 2011-06-03 2021-11-23 Allergan, Inc. Dermal filler compositions including antioxidants
US20130244943A1 (en) 2011-09-06 2013-09-19 Allergan, Inc. Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
US9662422B2 (en) 2011-09-06 2017-05-30 Allergan, Inc. Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
DK2934510T3 (da) * 2012-12-19 2021-01-25 Novartis Ag Lfa-1-inhibitorformuleringer
AT514540A1 (de) * 2013-06-18 2015-01-15 Apomedica Pharmazeutische Produkte Gmbh Ophthalmische Zusammensetzung
PL3613423T3 (pl) 2013-07-10 2023-02-13 Matrix Biology Institute Kompozycje hialuronanu o dużej sprężystości i ich zastosowanie
JPWO2015125921A1 (ja) * 2014-02-20 2017-03-30 わかもと製薬株式会社 保存効力を有する医薬用水性組成物
WO2016051219A1 (en) 2014-09-30 2016-04-07 Allergan Industrie, Sas Stable hydrogel compositions including additives
WO2016128783A1 (en) 2015-02-09 2016-08-18 Allergan Industrie Sas Compositions and methods for improving skin appearance
AU2016308818B2 (en) * 2015-08-18 2022-04-21 Astellas Institute For Regenerative Medicine Clinical formulations
RU2727809C2 (ru) 2015-09-24 2020-07-24 Матрикс Байолэджи Инститьют Композиции гиалуроновой кислоты с высокоэластичными свойствами и способы их применения
KR20190068575A (ko) * 2016-10-14 2019-06-18 이콤 메디칼 게엠베하 안구 표면 항상성의 확립, 회복 및 보존 방법
MX2020004922A (es) * 2017-11-22 2020-08-27 Bausch & Lomb Composiciones viscoelasticas oftalmicas.
CN113354757B (zh) * 2021-06-26 2022-04-08 上海加新生物科技有限公司 一种小分子透明质酸钠的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4141973A (en) 1975-10-17 1979-02-27 Biotrics, Inc. Ultrapure hyaluronic acid and the use thereof
US5409904A (en) * 1984-11-13 1995-04-25 Alcon Laboratories, Inc. Hyaluronic acid compositions and methods
US4886786A (en) * 1985-08-01 1989-12-12 Lindstrom Richard L Additive for irrigation solution or surgical solution
IL80298A (en) 1986-10-14 1993-01-31 Res & Dev Co Ltd Eye drops
US4920104A (en) * 1988-05-16 1990-04-24 Medchem Products, Inc. Sodium hyaluronate composition
JPH07116030B2 (ja) * 1990-06-29 1995-12-13 参天製薬株式会社 残留水晶体物質除去補助剤
WO1994007505A1 (en) * 1991-07-03 1994-04-14 Norpharmco Inc. Use of hyaluronic acid and forms to prevent arterial restenosis
JPH06107538A (ja) * 1992-03-31 1994-04-19 Shiseido Co Ltd 角膜移植用眼球保存液
JPH05310580A (ja) * 1992-04-30 1993-11-22 Shiseido Co Ltd 眼内灌流用液剤

Also Published As

Publication number Publication date
ITMI952744A1 (it) 1997-06-22
JP4146910B2 (ja) 2008-09-10
EP0781547A1 (en) 1997-07-02
CA2193543C (en) 2006-02-21
PT781547E (pt) 2002-09-30
CA2193543A1 (en) 1997-06-23
EP0781547B1 (en) 2002-04-17
DE69620724T2 (de) 2002-11-21
JPH09216826A (ja) 1997-08-19
US5880107A (en) 1999-03-09
ES2175020T3 (es) 2002-11-16
DE69620724D1 (de) 2002-05-23
ATE216221T1 (de) 2002-05-15
ITMI952744A0 (da) 1995-12-22
IT1277707B1 (it) 1997-11-11

Similar Documents

Publication Publication Date Title
DK0781547T3 (da) Ophthalmisk formulering baseret på natriumhyaluronat til anvendelse i øjen-kirugi
ATE482675T1 (de) Optisches implantat für die hornhaut
MX9702349A (es) Usos de derivado de 9-deoxi prostaglandina para tratar glaucoma.
DE69420196D1 (de) Ophtalmologische Vorrichtung für den vorderen Augenbereich
LV10688A (lv) Pretalergisks sastavs oftalmologijai vai deguna slimibam
CA2295061A1 (en) Storage-stable ophthalmic compositions comprising diclofenac and ofloxacin
AU4128901A (en) Colored visco-elastic composition
CA2436269A1 (en) Artificial tear composition containing a combination of three demulcents
WO2003022174A3 (en) Intraocular lens extracting device
WO2000018316A3 (en) Sustained release, and comfortable ophthalmic composition and method for ocular therapy
AU5446299A (en) Medicinal compositions for treating eye diseases
AU2002357972A1 (en) Heparin-containing ophthalmic agent
ES2052893T3 (es) Preparado de n-acetil-glucosamina para administracion por via bucal.
WO1998039293A3 (en) 13-thia prostaglandins for use in glaucoma therapy
DK1083929T3 (da) Anvendelse af anabolske stoffer
FI973060A0 (fi) Anti-inflammatorisia silmätippoja
ES2141843T3 (es) Utilizacion de amidoaminas en composiciones oftalmologicas.
ATE117208T1 (de) Behandlung von intraokularem druck mit einer ophthalmischen synergistischen kombination.
BR0115154A (pt) material viscoelástico transicional não-aspirante para uso em cirurgia
DE69100171D1 (de) Synergistische kombination zur ophthalmischen verwendung.
ATE202922T1 (de) Ophthalmische cromolyn-gelzubereitung
DE69914066D1 (de) Augenspüllösung
IT234988Y1 (it) Scivolasta correttore per protesi oculare in caso di assimetria anatomica delle orecchie.
MX9600140A (es) Uso de derivados de tocoferilo de vitamina e en composiciones oftalmicas.
UA29334A (uk) Очні краплі